Global Health Limited (AU:GLH)
ASX:GLH
Want to see AU:GLH full AI Analyst Report?
GLH Stock Chart & Stats
AU$0.09
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.09
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.05 - AU$0.14
Previous CloseN/A
Volume20.61K
Average Volume (3M)18.95K
Market Cap
AU$3.41M
Enterprise ValueAU$320.26B
Total Cash (Recent Filing)AU$1.04M
Total Debt (Recent Filing)AU$1.63M
Price to Earnings (P/E)59.6
Beta0.01
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding58,794,537
10 Day Avg. Volume15,411
30 Day Avg. Volume18,951
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-1.06
Price to Sales (P/S)0.46
P/FCF Ratio-5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth TrendConsistent top-line growth from ~A$6.0m to ~A$8.7m over five years indicates sustained customer traction and expanding adoption of GLH’s products. A rising revenue base provides a firmer runway to absorb fixed costs and supports continued investment in product and sales to drive durable scale.
SaaS Recurring Revenue ModelA subscription/SaaS revenue mix gives GLH higher revenue visibility, recurring cash flow potential and customer stickiness via platform integrations. Over months this supports predictable renewal-driven growth and upsell opportunities with hospitals and clinics, strengthening long-term revenue durability.
Gross Margin Recovery & Improving OperationsA strong gross margin rebound to ~24% and materially narrowed losses signal improving unit economics and operational leverage. If GLH sustains these margins while scaling subscriptions, the company can convert revenue growth into durable operating profitability over the medium term.
Bears Say
Negative Shareholders' EquityPersistent negative shareholders’ equity (~-A$3.7m) materially weakens the balance sheet, reducing capital-raising flexibility and increasing insolvency risk. This structural deficit constrains leverage capacity and makes the company more vulnerable to shocks over the coming months.
Persistent Negative Operating And Free Cash FlowOngoing negative operating and free cash flow, albeit improved from prior years, mean GLH still requires external funding to cover operations and investment. This structural cash shortfall limits ability to self-fund growth, risks dilution or restrictive financing terms, and pressures sustainability.
Small Scale Revenue Base And Limited ScaleA relatively small revenue base (~A$8.7m) and compact headcount (49) constrain economies of scale and market presence. This structural size limitation can slow R&D, sales expansion and margin improvement, making it harder to absorb shocks and lengthening the path to durable profitability.
Global Health Limited News
GLH FAQ
What was Global Health Limited’s price range in the past 12 months?
Global Health Limited lowest share price was AU$0.05 and its highest was AU$0.14 in the past 12 months.
What is Global Health Limited’s market cap?
Global Health Limited’s market cap is AU$3.41M.
When is Global Health Limited’s upcoming earnings report date?
Global Health Limited’s upcoming earnings report date is Sep 02, 2026 which is in 81 days.
How were Global Health Limited’s earnings last quarter?
Global Health Limited released its earnings results on Feb 25, 2026. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is Global Health Limited overvalued?
According to Wall Street analysts Global Health Limited’s price is currently Overvalued.
Does Global Health Limited pay dividends?
Global Health Limited pays a Quarterly dividend of AU$0.01 which represents an annual dividend yield of N/A. See more information on Global Health Limited dividends here
What is Global Health Limited’s EPS estimate?
Global Health Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Health Limited have?
Global Health Limited has 58,794,537 shares outstanding.
What happened to Global Health Limited’s price movement after its last earnings report?
Global Health Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Global Health Limited?
Currently, no hedge funds are holding shares in AU:GLH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Health Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-37.50%
12-Months-Change
Fundamentals
Return on Equity
15.41%
Trailing 12-Months
Asset Growth
-1.19%
Trailing 12-Months
Company Description
Global Health Limited
Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including specialized platforms for mental health practitioners like psychologists and psychiatrists. The company provides integrated solutions across community health and human services, encompassing areas such as drug and alcohol support, disability services, post-acute and community care, and rehabilitation. Furthermore, they offer solutions for home and aged care, general practice, pharmacies, and consumer engagement. Key products include the MasterCare Electronic Medical Record (EMR), MasterCare + for digitizing services, and MasterCare Patient Administration System (PAS). PrimaryClinic provides medical and practice management capabilities for GPs and specialists, enabling shared patient demographic data. Other significant tools are ReferralNet for secure document exchange, LifeCard as a personal health record, and HotHealth for digital patient engagement. Complementing these are the MasterCare Data Warehouse for streamlined data analysis, e-switch middleware for seamless system integration, a Patient Portal for digital pre-admission data capture, and Altitude, their cloud hosting service.
Technical Analysis
Epsilon Healthcare Limited
―
Ramsay Health Care
―
Paragon Care Limited
―
Regis Healthcare Ltd.
―
Freedom Care Group Holdings Limited
―